What You Don’t Know About Your Weed: 7 Cultivation Choices Consumers Never See

Pick up two jars of the same named strain from two different dispensaries. There is a real chance you are holding two different plants. Not similar plants grown differently. Genuinely different genetics, wearing the same name.

Nothing in U.S. cannabis regulation requires a strain name to mean anything consistent at all. That single fact is a useful way into a larger truth. Almost every decision that shapes a finished flower product happens somewhere a consumer will never see it.

The two data points buyers do get, THC percentage and how the bud looks in a jar, describe almost none of it.

What You Don’t Know About Your Weed: 7 Cultivation Choices Consumers Never See

Choice #1: Strain Name

Cultivators source genetics several ways. Some use cuttings passed grower to grower. Some use tissue-culture labs that store disease-free genetic stock. Others use feminized seed banks or run in-house breeding programs. None of these paths are standardized, and clones drift over time.

A 2019 study used DNA markers to test 122 products sold under 30 strain names across dispensaries in Colorado, Washington, and California. It found no genetic support for the indica, sativa, and hybrid framework at all. It also found real genetic inconsistency within the same strain name (Schwabe & McGlaughlin, 2019).

Blue Dream: A Strain Name with No Owner

A separate 2019 analysis by Leafly looked at terpene data. It found that Blue Dream, one of the most common strains sold nationally, splits into two distinct chemical types. 54% of tested samples were dominated by myrcene, the terpene most tied to the strain’s relaxed reputation. Another 24% were dominated by pinene instead. Close to half the jars labeled Blue Dream do not share the same lead terpene.

A name on a jar tells you what someone decided to call it. It does not tell you what is actually inside.

Choice #2: Light

Commercial growers choose among high-pressure sodium, ceramic metal halide, and LED lights. The choice usually comes down to cost versus spectrum. HPS is cheap and reliable but runs hot and skews toward red and orange light. LED is efficient and tunable, but costs more upfront.

The choice matters more than it might seem.

More Expensive Doesn’t Mean More Effect

A 2021 University of Guelph study raised light intensity across a wide range and tracked the results. Yield rose substantially, from 116 to 519 grams per square meter. Potency did not rise with it. Myrcene levels roughly doubled at the highest light levels tested, while limonene rose by about half (Rodriguez-Morrison et al., 2021a).

The same researchers later tested a popular claim: that UV-B light boosts cannabinoid content. They found no commercial benefit. In one cultivar, UV-B actually reduced THC and CBD content along with terpene levels and flower size (Rodriguez-Morrison et al., 2021b).
That has not stopped UV supplementation from remaining a common upsell in grow-light marketing. The gap between grower folklore and what controlled trials actually show turns up again and again in this industry.

Choice #3: Growing Medium and Climate

Whether a plant grows in living soil, coco coir, or a hydroponic system shapes cost, labor, and control more clearly than it shapes flavor, at least based on what has actually been measured.

Trade publications and grower forums are full of claims that soil-grown cannabis tastes richer than hydro-grown cannabis. But no rigorous, peer-reviewed study has directly compared terpene or cannabinoid outcomes across growing media.

An entire hierarchy in cannabis culture, soil as more natural and higher quality, hydro as more industrial, rests mostly on tradition and anecdote rather than demonstrated chemistry.

Climate control decisions are less visible but arguably matter more. Commercial rooms are tuned to a target humidity range that shifts across flowering, and getting it wrong cuts two different ways: high humidity favors botrytis, the mold known as bud rot. Powdery mildew actually thrives in warmer, drier conditions instead, so a room managed against one risk can walk straight into the other (Cannabis Business Times, 2017).

Rooms are also commonly enriched with extra carbon dioxide during light hours to speed up photosynthesis. None of these choices get disclosed to the person buying the final product.

Choice #4: Pest and Disease Management

Pest and disease management is where “passed testing” and “grown clean” can most visibly pull apart. The clearest warning case involves myclobutanil, sold under brand names including Eagle 20. This fungicide converts to hydrogen cyanide gas when burned.
  • Colorado issued dozens of product recalls tied to banned pesticides starting in 2015
  • In Washington state, cultivators New Leaf Enterprises and BMF Washington were ordered to stop sales over unauthorized pesticide use (Coughlin-Bogue, 2016).
  • In Canada, Mettrum Ltd. (acquired by Canopy Growth) issued an expanded recall in late 2016 after contamination was found (New Cannabis Ventures, 2016). Health Canada was slow to disclose the contamination publicly.

What’s On the Plant, Tested or Not

Nearly a decade later, the problem has not disappeared.
  • A 2024 report and a separate investigative series both found banned pesticides continuing to surface in California’s legal market, despite mandatory testing (Beyond Pesticides, 2024; SFGATE, 2024).
  • A Sacramento-area lab was separately accused of faking pesticide test results outright (CBS San Francisco, 2018). That meant some contaminated product never had a fair chance of getting caught at all.
Growers say integrated pest management, meaning beneficial insects, sanitation, and careful scouting, is their first line of defense. But the pressure to protect a crop worth months of investment means the real pest-control decisions a grower makes stay invisible to anything a consumer can check.

Choice #5: Harvest Time

The near-universal method for timing harvest is visual. Cultivators watch trichomes shift from clear to cloudy to amber under magnification, then cut based on that color. It is treated as a stand-in for cannabinoid maturity.

It is a genuinely useful shortcut, but a 2025 review of the underlying trichome research found the science behind it thinner than growers assume: trichome density itself varies widely across different parts of the same flower. Much of the published data measuring that density was never designed to validate the color-based cutting decision growers actually make in the field (Alberti et al., 2025).

In commercial facilities, harvest timing is often driven as much by room-turnover schedules and labor availability as by the plant’s ideal chemical moment. That fact rarely appears in marketing copy built around “hand-selected, perfectly ripened” flower.

Choice #6: Dry and Cure

Post-harvest handling may be the single most consequential, and most invisible, set of decisions in the entire process.

A 2022 review of drying and curing methods supports what careful growers have long claimed by feel: slower, cooler drying preserves more terpene content than fast, hot drying, with freeze-drying outperforming the other methods compared (AL Ubeed et al., 2022).

Industry guides commonly recommend a method growers call “60/60”: drying around 60 degrees Fahrenheit and 60 percent humidity, with the exact duration adjusted by feel rather than a fixed schedule (DriFlower, 2024). That specific combination reflects grower consensus more than one peer-reviewed study.

Curing practice has shifted from tracking raw moisture to tracking something called water activity: growers generally target a “sweet spot” of roughly 0.55 to 0.62 for flavor and trichome preservation, while treating 0.65 as a safety ceiling above which mold risk climbs sharply (AROYA, n.d.).

Standard practice involves opening sealed jars several times a day for two to four weeks, tapering off as the cure stabilizes. None of that shows up on a label.

Neither does what happens after the product leaves the curing room. Cannabis oxidizes and loses terpene content on dispensary shelves under light, heat, and improper humidity, the same degradation pathways the post-harvest research above already documents for drying and curing (AL Ubeed et al., 2022). The potency and terpene content tested weeks earlier may not match what is actually in the jar at the register.

Choice #7: Remediation

Remediation is the least visible step of all. When a batch fails a microbial test, growers can often treat it with radiation or ozone and retest it rather than destroy it; several legal states allow some form of this.

The Maine Lab Scandal

A 2026 investigation documented how widespread the practice has become in Maine specifically, where one industry estimate put roughly half the state’s recreational supply through some form of treatment. Regulators confirmed they had stopped enforcing an on-the-books disclosure requirement after industry pushback.

A lab director interviewed for that story noted that treatment does not guarantee contamination stays gone. Mold can resurface in a treated batch months later, and a passing retest detects presence, not whether the underlying problem was actually solved (Tusinski, 2026).

Why You Don’t Know What You Don’t Know About Your Weed

Every legal state requires seed-to-sale tracking systems. These systems already log an enormous amount of information for regulatory traceability. That includes genetics, room conditions, pesticide applications, harvest and cure dates, and remediation events. Almost none of it is designed to reach the consumer.

That is partly a labeling-space problem and partly a competitive one. A cultivator’s specific light recipe, cure schedule, or pest-management protocol is treated as proprietary know-how, not information owed to the buyer.

A few premium and craft brands try to close this gap voluntarily. They publish grow logs, harvest dates, or extra lab results alongside the standard COA. That remains a marketing choice made by a small slice of the market, not a baseline a buyer can count on.

What You Do Know About Your Weed

None of these decisions are hidden out of malice. Most exist because the current system was built to check for safety and potency, not to document a product’s full history. Disclosing every cultivation choice would also be commercially and logistically enormous.

But the cumulative effect is a finished product that arrives at the dispensary counter almost entirely stripped of its own story.
  • Genetics may not match the name on the label.
  • Light and climate decisions shaped its chemistry in ways no certificate reports.
  • Pest pressure and harvest timing were driven as much by scheduling as by botany.
  • A post-harvest process, including possible remediation, happened entirely out of view.
A THC percentage and a good-looking bud are what is left after all of that. That is exactly why they were never enough to go on in the first place.

A buyer who wants more than that can still do a few concrete things: ask when the flower was harvested, ask whether it was remediated, favor brands willing to publish full terpene results voluntarily instead of the bare minimum a state requires, and buy from stores with enough turnover that flower is not sitting under lights for weeks before it sells.

It is also worth treating an unusually high THC percentage with some skepticism, since testing-lab inflation is its own well-documented invisible choice, one made by a lab rather than a grower, but no less hidden from the person buying the jar.

None of it fully closes the gap between what’s grown and what’s known. It gives a buyer more to go on than a strain name and a number.

Subscribe to Fat Nugs Magazine!

Love this article? Show your support for Fat Nugs with a magazine subscription!

As a fully independent media organization, Fat Nugs relies on the grassroots support of individuals like you to continue to write and share these articles. Every subscription helps us keep bringing you the unbiased, broad-ranging cannabis, hemp, and psychedelics articles like these.

About the Author

RN Collins is the staff writer at Fat Nugs Magazine, as well as 1L at Northeastern University School of Law and a neuroscientist exploring how brain health and the environment intersect. Through her writing, she bridges academic research and science communication to reframe how psychoactive plants and other traditional and alternative medicines are understood. She’s building a career that connects law, technology, and creativity—and welcomes conversations and opportunities across fields that share that vision. Connect with her on LinkedIn!

References

Search for Articles